Prior treatment with cancer drug likely renders COVID-19 vaccine ineffective, study finds: Rituximab, a drug widely used in patients with lymphoma, blunts or eliminates the antibody response to COVID-19 vaccines if it is administered before them, Stanford researchers say.
No comments:
Post a Comment